Biozen Health Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 49.10%
- Profit Growth 13.90%
- Ebitda 4.36%
- Net Worth 29.15%
- Total Assets 43.96%
About Biozen Health Products
Biozen Health Products Private Limited (BHPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 February 2013 and has a history of 11 years and 11 months. Its registered office is in Kanpur, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Surjeet Pramanik and Mitali Pramanik serve as directors at the Company.
Company Details
- Location
Kanpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51101UP2013PTC055234
- Company No.
055234
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Biozen Health Products Private Limited offer?
Biozen Health Products Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Arthritic Drugs.
Who are the key members and board of directors at Biozen Health Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surjeet Pramanik  | Director | 25-Feb-2013 | Current |
| Mitali Pramanik | Director | 25-Feb-2013 | Current |
Financial Performance of Biozen Health Products.
Biozen Health Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.1% increase. The company also saw a substantial improvement in profitability, with a 13.9% increase in profit. The company's net worth Soared by an impressive increase of 29.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biozen Health Products?
In 2023, Biozen Health Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biozen Health Products?
Biozen Health Products has a workforce of 81 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biozen Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biozen Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.